EWG Elevate’s Johnson & Johnson JNJ Stock Holding History

EWG Elevate’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-612	Closed	-$108K	–	425
2022 Q4	$108K	Buy	+612	New	+$106K	0.05%	114

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

EWG Elevate's JNJ Position: Q1 2023 in Review

EWG Elevate sold out of Johnson & Johnson (JNJ) in Q1 2023, closing a stake of 612 shares — an estimated $108K sold.

EWG Elevate first reported a position in JNJ in Q4 2022 and held it in 1 quarter. The position peaked at $108K in Q4 2022. 3,729 funds tracked by Wall St. Rank hold JNJ as of Q1 2023.

EWG Elevate reported no remaining Johnson & Johnson position as of Q1 2023 after selling out during the quarter.
EWG Elevate sold 612 Johnson & Johnson shares in Q1 2023, an estimated $108K.
EWG Elevate first reported a position in Johnson & Johnson in Q4 2022 and held it in 1 quarter.
EWG Elevate's Johnson & Johnson position peaked at $108K in Q4 2022.
3,729 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2023.

Based on EWG Elevate's 13F filing for Q1 2023, filed 13 Apr 2023.